Company / Depreciation & Amortization
Perspective Therapeutics, Inc. Depreciation & Amortization History
FY2013-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$136.0K
FY2021
5-year range
$68.0K / $471.0K
FY2017-FY2021
Trend
+70.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $68,000 to $136,000 over the past 2 years.
Based on SEC 10-K filings.
$136,000 in FY2021 with a 5-year CAGR of -27.6%.
Increased from $68,000 to $136,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -33.9%
- 5-Year CAGR
- -27.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -27.6%, indicating a declining trend.
- In FY2021, depreciation & amortization increased 70.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2013.
- Lowest depreciation & amortization in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | $136.0K | +70.0% |
| FY2020 | $80.0K | +17.6% |
| FY2019 | $68.0K | -85.6% |
| FY2018 | $471.0K | -18.2% |
| FY2017 | $576.0K | -16.0% |
| FY2016 | $685.4K | -7.3% |
| FY2015 | $739.1K | +0.0% |
| FY2014 | $739.1K | -12.7% |
| FY2013 | $847.1K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026